Subgroup analysis showed that high expression of RBMS3 significantly affected the overall survival of M0 (P=0.005), N1/N2 (P=0.018), and T3/T4 (P=0.006) lung cancer patients, respectively (Figure 4E-G). This evidence concerns the gene RBMS3 and lung carcinoma.